secwatch.observer — SEC 8-K summary
======================================

Issuer:     Biohaven Ltd. (BHVN)
CIK:        0001935979
Form:       8-K
Filed at:   2024-08-16T23:59:59+00:00
Accession:  0001628280-24-037568
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biohaven expands at-the-market equity facility by $300M to total potential issuance
--------------------------------------------------------------------------------

- Amendment No. 1 increases existing ATM capacity by $300M in common shares; sales via J.P. Morgan as manager.
- New shares offered under effective shelf registration (333-274822) with prospectus supplement filed August 16, 2024.
- Sales depend on market conditions, share price, and capital needs; timing and amounts are at company's discretion.
- Original Equity Distribution Agreement dated October 2, 2023; prior capacity not disclosed in this filing.
- Proceeds from any sales will be used for general corporate purposes as determined by management.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1935979/000162828024037568/0001628280-24-037568-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1935979/000162828024037568/bhvn-20240816.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-037568

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer